Loading financial data...

Mosaic ImmunoEngineering Inc. (CPMV) Financial Statements | Global Financial Data

Mosaic ImmunoEngineering Inc.

CPMVSEC EDGAR

Biological Products, (No Diagnostic Substances)(DE)CIK: 836564

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Research and Development Expense	$435.4K	$1.0M	$1.5M	$0.00	—
Selling, General and Administrative Expense	—	—	—	—	$734.1K
Operating Expenses	$1.4M	$2.6M	$3.5M	$511.00	$734.1K
Operating Income (Loss)	-$1.4M	-$2.6M	-$3.5M	—	—
Interest Expense	—	—	—	—	—
Nonoperating Income (Expense)	$393.9K	$249.1K	-$180.9K	$0.00	-$62.8K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$1.0M	-$2.4M	-$3.7M	$0.00	—
Income Tax Expense (Benefit)	$2.4K	$2.4K	$2.4K	$0.00	$1.6K
Net Income (Loss) Attributable to Parent	-$1.0M	-$2.4M	-$3.7M	-$511.00	-$798.5K
Earnings Per Share, Basic	-$0.14	-$0.33	-$0.55	$0.00	$0.00
Earnings Per Share, Diluted	-$0.14	-$0.33	-$0.55	$0.00	$0.00

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$179.5K	$261.3K	$269.5K	$457.8K	$1.9M
Assets, Current	$179.5K	$261.3K	$269.5K	$457.8K	$1.8M
Cash and Cash Equivalents, at Carrying Value	$156.2K	$220.6K	$226.1K	$352.7K	$787.1K
Liabilities	$6.1M	$5.1M	$3.1M	$880.3K	$228.2K
Liabilities, Current	$4.7M	$3.9M	$2.3M	$880.3K	$228.2K
Accounts Payable, Current	$118.5K	$133.5K	$113.5K	$86.0K	$8.9K
Stockholders' Equity Attributable to Parent	-$4.9M	-$2.8M	-$422.5K	$0.00

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$497.5K	-$690.1K	-$679.2K	$500.00	-$760.8K
Net Cash Provided by (Used in) Investing Activities	$433.0K	$343.0K	$27.6K	$0.00	-$572.8K
Net Cash Provided by (Used in) Financing Activities	$0.00	$341.6K	$525.0K	$0.00	—
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—
Payments for Repurchase of Common Stock	—	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)